GSK plc (NYSE:GSK) is one of the best affordable healthcare stocks to buy now. GSK plc (NYSE:GSK) announced on December 19 an ...

An announcement from GlaxoSmithKline ( ($GB:GSK) ) is now available. GSK plc has continued its share buyback programme, repurchasing 232,912 ...

GSK's major growth drivers, Shingrix and Arexvy, along with recent legal progress, make its current undervaluation unjustified, leading to a "Strong Buy" rating. The company’s diversified portfolio ...

We recently published 13 Best ADR Stocks to Invest In. GSK plc (NYSE:GSK) is one of the best ADR stocks. GSK plc (NYSE:GSK) is one of the largest pharmaceutical companies in the world. The firm scored ...

GSK GSK stock has risen 16.9% year to date compared with an increase of 7.0% for the industry. The stock has also outperformed the sector and the S&P 500 index, as seen in the chart below. The stock ...

GSK (NYSE:GSK) continued losses for a seventh straight session as the stock closed 0.61% lower, at $37.51 on Friday. The British pharmaceutical company lost 3.13% in the last six trading sessions. The ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research ...

GSK (GSK), a large British drug maker, is rallying 8% after reporting higher-than-expected fourth-quarter earnings per share and raising its long-term revenue guidance. Last quarter, its operating ...

That news concerns a discontinued version of GSK's blockbuster heartburn drug Zantac, which was the focus of a series of lawsuits alleging that its active ingredient caused cancer. GSK announced ...

Gonorrhoea is a common, sexually transmitted infection caused by Neisseria gonorrhoeae. GSK said, in 2023, there were over 600,000 cases of gonorrhoea reported in the United States according to the ...